CAS RN: 1427439-38-0
—
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260626
100mg / 250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1427439-38-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1427439-38-0 / 4-bromo-3-chloro-5-fluorobenzonitrile
Standard CAS: 1427439-38-0
Multi CAS: No
Basic Information
copy
CAS
1427439-38-0 copy
Multi CAS
No copy
Molecular Formula
C7H2BrClFN copy
Molecular Weight
234.450000 copy
Exact Mass
232.904320 copy
SMILES
C1=C(C=C(C(=C1F)Br)Cl)C#N copy
InChI
InChI=1S/C7H2BrClFN/c8-7-5(9)1-4(3-11)2-6(7)10/h1-2H copy
InChIKey
GYSVMEBLBGRYCE-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
1 copy
Molar refractivity
43.83 copy
TPSA
23.79 copy
LogP / Solubility
WLOGP
3.11 copy
MLOGP
2.74 copy
XLogP3
3.1 copy
Consensus LogP
2.98 copy
Log S (ESOL)
-3.66 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.73 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.77 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.94 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy